Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

CMAB raises $34M for manufacturing upgrade

April 2, 2018 4:21 PM UTC

CMAB Biopharma Inc. (Suzhou, China) raised $34 million in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed.

CMAB said it will upgrade its biologics production facilities and expand manufacturing capacity. The facilities will meet global GMP standards and will initially focus on manufacturing preclinical and early stage clinical supplies for companies in China and worldwide. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

CMAB Biopharma (Suzhou) Inc.